In this photo illustration, a smartphone displays the logo of Doximity, Inc. (NYSE: DOCS), a U.S.-based digital healthcare company providing a professional networking platform and cloud-based tools for physicians and medical professionals, in front of a screen showing the company’s latest stock market chart, on January 29, 2026, in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)

...

Alexis Kayser

By Alexis Kayser

Healthcare Editor

0

Share

Newsweek is a Trust Project member

See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.


Today’s Doximity earnings call revealed that 300,000 unique clinicians used the company’s AI tools in the last three months of 2025. According to Dr. Eric Topol, founder and director of the Scripps Research Translational Institute, that number is likely to keep climbing throughout 2026.

“Doximity’s community is humungous,” Topol told Newsweek in an exclusive interview, ahead of the much-anticipated Q3 report. “It’s 3 million clinicians, virtually every clinician in the country. There’s just no other medical community that has this many active participants.”

Topol recently teamed up with Doximity to co-chair its new PeerCheck feature, alongside Dr. Regina Benjamin, the 18th Surgeon General of the United States. PeerCheck involves physicians in the oversight of Doximity’s generative AI tools, asking original report authors and subject matter experts to review and refine the chatbot’s responses.

Read More on Health Care

PeerCheck-ed answers are expected to appear on DoxGPT, Doximity’s tool that can draft prior authorization letters, patient education materials and research grant applications, by the end of the week. More than 10,000 physicians have participated in the PeerCheck process ahead of the feature’s launch, according to Topol—illustrating the desire for AI tools that doctors know they can trust.

“From everything I see, it looks like PeerCheck is going to be remarkably popular,” Topol said.

In this photo illustration, a smartphone displays the logo of Doximity, Inc. (NYSE: DOCS), a U.S.-based digital healthcare company providing a professional networking platform and cloud-based tools for physicians and medical professionals, in front of a screen showing the company's latest stock market chart, on January 29, 2026, in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)

...

Both Topol and Benjamin were big wins for the medical tech platform, which initially claimed fame as a networking and news site for doctors. Doximity expanded its digital capabilities over the years, adding a telemedicine platform, secure doc-to-patient “dialer” and a fax feature that allowed clinicians to dispatch from anywhere in the world.

The trust Doximity built with its user base paid off when the company cracked the competitive health AI market. CEO Jeff Tangney said he isn’t concerned about going head-to-head with medically tailored AI offerings from OpenAI, Anthropic and other household names.

“OpenAI’s health bench has 260 doctors who are reviewing some of their answers,” Tangney told Newsweek. “But if you have a neuroendocrine Stage IV tumor, you want the person who studied that tumor type, has done clinical trials, is cited in the literature on it and is really the expert—not just the general practice physician or even an oncologist.”

“That ability to really go deep with the breadth of 10,000 experts is really our key value,” he continued. “There are lots of niches in medicine, and the reality is, you can’t cover it with just a couple hundred doctors.”

To date, Doximity has signed more than 100 enterprise agreements with health systems that started implementing their AI tools in January. The roster includes Scripps Health, UCHealth, UC San Diego Health, Prisma Health and the University of Rochester Medical Center.

Doximity expects these partnerships to expand access to more than 175,000 clinicians—so health systems are a major target for the company’s AI strategy in 2026, according to Tangney.

“We’re leaning more into the enterprise here, and it’s gone very well,” he said.

The company’s Feb. 5 earnings report noted a 10 percent revenue increase year over year, comparing October-December 2024 with the same period in 2025. Its nascent AI products had more than 300,000 users during that three-month span; its newsfeed saw more than 1 million active subscribers; and its workflow products sported 720,000 users, a record increase quarter over quarter.

Topol told Newsweek that he’s encouraged by the early engagement in PeerCheck, as he expected physician involvement to be the most challenging part of the initiative.

“I guess because AI is so big right now, there’s tremendous enthusiasm within the medical community for academics and leaders to be part of a solution, and not just be complacent with part of the problem,” Topol said. “I didn’t anticipate that.”

View 0 Comments

Request Reprint & Licensing

Submit Correction

View Editorial & AI Guidelines